Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01819181 · ClinicalTrials.gov registry record

Women's INternational Transcatheter Aortic Valve Implantation Registry

A clinical trial of Symptomatic Aortic Stenosis, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
1,019
Enrollment target
10
Study locations

NCT01819181: Completed study of Symptomatic Aortic Stenosis, sponsored by Icahn School of Medicine at Mount Sinai.

NCT01819181 is a study of Symptomatic Aortic Stenosis that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,019 participants. The trial reports 10 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01819181, a study of Symptomatic Aortic Stenosis, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
1,019 participants
Enrollment target
10
Study locations

Study Summary

The study will evaluate all female patients with severe aortic stenosis undergoing transcatheter valve implantation with commercially available valves and delivery systems.

Primary Outcome

The primary study endpoint is the VARC 2 early safety endpoint at 30-days (all-cause mortality, all stroke \[disabling and non disabling\], life-threatening bleeding, stage 2 or 3 acute kidney injury \[AKI\], coronary artery obstruction requiring intervention, major vascular complications, repeat procedure for valve-related dysfunction).

Study Locations (10)

Other

  • Hôpital Privé Parly 2 - Le Chesnay
  • Azienda Ospedaliero - Ferrarotto Alessi - Catania
  • Instituto Clinico Humanitas - Milan
  • San Raffaele Hospital - Milan
  • Department cardiovascular Sciences Policlinico Umberto I - Rome
  • Radboud University Nijmegen Medical Center - Nijmegen
  • Erasmus Medical Center Rotterdam - Rotterdam
  • Hospital Universitario Miguel Servet - Zaragoza
  • Imperial College - London

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 1,019 participants
Start Date 2013-03
Est. Completion 2018-04-26

What the finished NCT01819181 record still lists

NCT01819181 is an observational study that tracks outcomes without assigning an intervention. Its 1,019 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Symptomatic Aortic Stenosis appearing as the primary indexed condition, and to 0 interventions.

NCT01819181 lists 10 locations in 2 states (Other, New York).

Frequently Asked Questions

What is clinical trial NCT01819181 about?

NCT01819181 is a clinical study titled "Women's INternational Transcatheter Aortic Valve Implantation Registry". The study will evaluate all female patients with severe aortic stenosis undergoing transcatheter valve implantation with commercially available valves and delivery systems.

What is the current status of trial NCT01819181?

This trial is currently completed. The enrollment target is 1,019 participants. The study started on 2013-03. Estimated completion is 2018-04-26.

What conditions does trial NCT01819181 study?

This clinical trial studies the following conditions: Symptomatic Aortic Stenosis.

Who is sponsoring clinical trial NCT01819181?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01819181 being conducted?

This trial has 10 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Symptomatic Aortic Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02178163 · 1,020 participants · NA

    Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer

  • NCT05225428 · 1,020 participants · NA

    Video Education With Result Dependent dIsclosure

  • NCT06697600 · 1,020 participants · NA

    A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

  • NCT06760637 · 1,020 participants · Phase 3

    Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01819181, the US trial registry maintained by the National Library of Medicine. NCT01819181 (large enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.